Alzheimer Disease

>

Latest News

dementia
Treatment Options for the Management of Behavioral and Psychological Symptoms of Dementia

July 18th 2024

The behavioral and psychological symptoms of dementia contribute significantly to the greater rates morbidity and mortality among those with dementia.

FDA approval
Alzheimer Disease Treatment Donanemab Receives FDA Approval

July 2nd 2024

Here are highlights from the week in Psychiatric Times.
The Week in Review: June 10-14

June 15th 2024

alzheimer
Donanemab: FDA Advisors Unanimously Recommend for Approval

June 10th 2024

Video Interviews
Podcasts

More News

© 2024 MJH Life Sciences

All rights reserved.